Kuang Lung Precision-KY: Announcement of Board of Directors' Approval of Consolidated Financial Report for the First Quarter of 2026

1. Date of submission to the Board of Directors or resolution by the Board: 2026/05/11 2. Date of Audit Committee approval: 2026/05/11 3. Reporting period for financial report or annual self-reported financial information (XXX/XX/XX~XXX/XX/XX): 2026/01/01~2026/03/31 4. Accumulated operating revenue from January 1st to the current period (thousand NTD): 279,274 5. Accumulated gross profit (or loss) from January 1st to the current period (thousand NTD): 92,816 6. Accumulated operating income (or loss) from January 1st to the current period (thousand NTD): 46,646 7. Accumulated profit (or loss) before tax from January 1st to the current period (thousand NTD): 39,323 8. Accumulated net profit (or loss) for the period from January 1st to the current period (thousand NTD): 29,871 9. Accumulated net profit (or loss) attributable to owners of the parent from January 1st to the current period (thousand NTD): 29,877 10. Basic earnings per share (loss) from January 1st to the current period (NTD): 0.88 11. Total assets at the end of the period (thousand NTD): 2,558,647 12. Total liabilities at the end of the period (thousand NTD): 1,268,711 13. Equity attributable to owners of the parent at the end of the period (thousand NTD): 1,288,112 14. Other matters to be stated: None